Your browser doesn't support javascript.
loading
Treatable traits: a comprehensive precision medicine approach in interstitial lung disease.
Khor, Yet H; Cottin, Vincent; Holland, Anne E; Inoue, Yoshikazu; McDonald, Vanessa M; Oldham, Justin; Renzoni, Elisabetta A; Russell, Anne Marie; Strek, Mary E; Ryerson, Christopher J.
Afiliação
  • Khor YH; Respiratory Research@Alfred, Central Clinical School, Monash University, Melbourne, Australia yet.khor@monash.edu.
  • Cottin V; Department of Respiratory and Sleep Medicine, Austin Health, Heidelberg, Australia.
  • Holland AE; Institute for Breathing and Sleep, Heidelberg, Australia.
  • Inoue Y; Faculty of Medicine, University of Melbourne, Melbourne, Australia.
  • McDonald VM; National Coordinating Reference Centre for Rare Pulmonary Diseases, OrphaLung, Louis Pradel Hospital, Hospices Civils de Lyon, ERN-LUNG, Lyon, France.
  • Oldham J; UMR 754, Claude Bernard University Lyon 1, INRAE, Lyon, France.
  • Renzoni EA; Respiratory Research@Alfred, Central Clinical School, Monash University, Melbourne, Australia.
  • Russell AM; Institute for Breathing and Sleep, Heidelberg, Australia.
  • Strek ME; Department of Respiratory and Sleep Medicine, Alfred Health, Melbourne, Australia.
  • Ryerson CJ; Department of Physiotherapy, Alfred Health, Melbourne, Australia.
Eur Respir J ; 62(1)2023 07.
Article em En | MEDLINE | ID: mdl-37263752
ABSTRACT
Interstitial lung disease (ILD) is a diverse group of inflammatory and fibrotic lung conditions causing significant morbidity and mortality. A multitude of factors beyond the lungs influence symptoms, health-related quality of life, disease progression and survival in patients with ILD. Despite an increasing emphasis on multidisciplinary management in ILD, the absence of a framework for assessment and delivery of comprehensive patient care poses challenges in clinical practice. The treatable traits approach is a precision medicine care model that operates on the premise of individualised multidimensional assessment for distinct traits that can be targeted by specific interventions. The potential utility of this approach has been described in airway diseases, but has not been adequately considered in ILD. Given the similar disease heterogeneity and complexity between ILD and airway diseases, we explore the concept and potential application of the treatable traits approach in ILD. A framework of aetiological, pulmonary, extrapulmonary and behavioural and lifestyle treatable traits relevant to clinical care and outcomes for patients with ILD is proposed. We further describe key research directions to evaluate the application of the treatable traits approach towards advancing patient care and health outcomes in ILD.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doenças Pulmonares Intersticiais / Medicina de Precisão Tipo de estudo: Diagnostic_studies / Prognostic_studies Limite: Humans Idioma: En Revista: Eur Respir J Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Austrália

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doenças Pulmonares Intersticiais / Medicina de Precisão Tipo de estudo: Diagnostic_studies / Prognostic_studies Limite: Humans Idioma: En Revista: Eur Respir J Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Austrália